Home

Lebeg ítélet Equip oncology overall survival diagram endometrium carcinoma Határ teljes optimális

Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated  With Immune-cell Therapy: A Retrospective Study | Anticancer Research
Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study | Anticancer Research

Natural history of recurrences in endometrial carcinoma
Natural history of recurrences in endometrial carcinoma

Endometrial cancer - Wikipedia
Endometrial cancer - Wikipedia

Comparison of overall survival and progression-free survival in... |  Download Scientific Diagram
Comparison of overall survival and progression-free survival in... | Download Scientific Diagram

Expanded Role for Immunotherapy to Treat Endometrial Cancer - NCI
Expanded Role for Immunotherapy to Treat Endometrial Cancer - NCI

Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities  Within Subsets of the US Black Population
Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population

Endometrial cancer - Wikipedia
Endometrial cancer - Wikipedia

Endometrial cancer among a cohort of urban Haitian immigrants
Endometrial cancer among a cohort of urban Haitian immigrants

Adjuvant chemotherapy for stage I high-intermediate risk endometrial  carcinoma with lymph-vascular invasion | International Journal of  Gynecologic Cancer
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer

NEJM on X: "In women with advanced endometrial cancer, the median progression-free  survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months  with chemotherapy; the median overall survival was 18.3 months
NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen  receptor immunohistochemistry | British Journal of Cancer
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry | British Journal of Cancer

Molecular Characterization of Second Primary Endometrial Cancer |  Anticancer Research
Molecular Characterization of Second Primary Endometrial Cancer | Anticancer Research

Time to first recurrence, pattern of recurrence, and survival after  recurrence in endometrial cancer according to the molecular classification  - ScienceDirect
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect

Survival outcomes in endometrial cancer patients according to diabetes: a  systematic review and meta-analysis | BMC Cancer | Full Text
Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text

Overall survival in endometrial cancer patients according to histologic...  | Download Scientific Diagram
Overall survival in endometrial cancer patients according to histologic... | Download Scientific Diagram

Kaplan-Meier estimates of overall survival. The three groups are:... |  Download Scientific Diagram
Kaplan-Meier estimates of overall survival. The three groups are:... | Download Scientific Diagram

Impact of treatment modality on overall survival in women with advanced endometrial  cancer: A National Cancer Database analysis - Gynecologic Oncology
Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis - Gynecologic Oncology

Cancers | Free Full-Text | Recurrent Endometrial Cancer: Local and Systemic  Treatment Options
Cancers | Free Full-Text | Recurrent Endometrial Cancer: Local and Systemic Treatment Options

Final validation of the ProMisE molecular classifier for endometrial  carcinoma in a large population-based case series - ScienceDirect
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series - ScienceDirect

Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial  Cancer: Could We Improve Their Accuracy?
Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?

Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial  cancer survival | British Journal of Cancer
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival | British Journal of Cancer

Natural history of recurrences in endometrial carcinoma
Natural history of recurrences in endometrial carcinoma

Survival-curve of 38 patients with Stage IVB endometrial cancer by... |  Download Scientific Diagram
Survival-curve of 38 patients with Stage IVB endometrial cancer by... | Download Scientific Diagram

Kaplan-Meier plot of Overall Survival (OS) in advanced endometrial... |  Download Scientific Diagram
Kaplan-Meier plot of Overall Survival (OS) in advanced endometrial... | Download Scientific Diagram

A) Recurrence-free survival, (B) disease-specific survival and (C)... |  Download Scientific Diagram
A) Recurrence-free survival, (B) disease-specific survival and (C)... | Download Scientific Diagram

A clinically applicable molecular-based classification for endometrial  cancers | British Journal of Cancer
A clinically applicable molecular-based classification for endometrial cancers | British Journal of Cancer

Recurrence and survival of patients with stage III endometrial cancer after  radical surgery followed by adjuvant chemo- or chemoradiotherapy: a  systematic review and meta-analysis | BMC Cancer | Full Text
Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis | BMC Cancer | Full Text